|
Volumn 31, Issue 2, 2001, Pages 109-113
|
Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I
|
Author keywords
FAB I; Lipid synthesis; Plasmodium falciparum; Toxoplasma gondii; Triclosan
|
Indexed keywords
CHLOROQUINE;
ENOYL ACYL CARRIER PROTEIN REDUCTASE;
FAB 1;
MEFLOQUINE;
OXIDOREDUCTASE;
PROTOZOAL PROTEIN;
TRICLOSAN;
UNCLASSIFIED DRUG;
ANTIPROTOZOAL ACTIVITY;
ARTICLE;
DRUG MECHANISM;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
LIPOGENESIS;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PLASMODIUM FALCIPARUM;
TOXOPLASMA GONDII;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIMALARIALS;
ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH);
ENZYME INHIBITORS;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR SEQUENCE DATA;
OXIDOREDUCTASES;
PLASMODIUM FALCIPARUM;
SEQUENCE ALIGNMENT;
TOXOPLASMA;
TRICLOSAN;
ANIMALIA;
BRASSICA NAPUS;
CORYNEBACTERINEAE;
ESCHERICHIA COLI;
FUNGI;
PLASMODIUM FALCIPARUM;
TOXOPLASMA GONDII;
|
EID: 0035119443
PISSN: 00207519
EISSN: None
Source Type: Journal
DOI: 10.1016/S0020-7519(01)00111-4 Document Type: Article |
Times cited : (197)
|
References (18)
|